Magnesium as the missing link in migraine control

Migraine is a widespread and disabling neurological condition marked by recurrent headache episodes, often accompanied by nausea, sensitivity to light, and reduced daily functioning. Despite advances in pharmacological treatment, many patients continue to experience incomplete relief. Increasing attention is being directed toward metabolic and nutritional factors, particularly magnesium deficiency, as a potentially modifiable contributor to both the onset and progression of migraine.

Magnesium is essential for normal neuronal activity and vascular regulation. It supports energy production, stabilizes nerve membranes, and modulates neurotransmitter release. Low magnesium levels may increase neuronal excitability, promote cortical spreading depression, and contribute to inflammatory and oxidative processes—all mechanisms linked to migraine pathophysiology. Importantly, deficiency is common across populations and may not always be detected by standard serum measurements, suggesting that subclinical depletion could play a role in migraine susceptibility.

Clinical findings indicate that magnesium supplementation may reduce migraine frequency, intensity, and duration. Intravenous magnesium has shown rapid effects in acute attacks, while oral supplementation appears beneficial in prevention strategies. However, results are not entirely consistent, likely due to differences in study design, patient selection, and dosing regimens.

Magnesium remains a well-tolerated and accessible option that can complement standard migraine therapies. While further large-scale studies are needed, optimizing magnesium intake—through diet or supplementation—offers a practical and low-risk approach within a comprehensive migraine management plan.